AKT1 and breast cancer: The artemisia herb derivate Dihydroartemisinin inhibits osteoclast differentiation as well as proliferation, migration, and invasion of breast cancer cells in vitro through suppression of AKT phosphorylation in osteoclasts and breast cancer cells.